Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials

Langbaum JB, Zissimopoulos J, Au R, Bose N, Edgar CJ, Ehrenberg E, Fillit H, Hill CV, Hughes L, Irizarry M, Kremen S, Lakdawalla D, Lynn N, Malzbender K, Maruyama T, Massett HA, Patel D, Peneva D, Reiman EM, Romero K, Routledge C, Weiner MW, Weninger S, Aisen PS.

Alzheimers Dement. 2023 Feb;19(2):696-707. doi: 10.1002/alz.12737. Epub 2022 Aug 10.

Autophagy Balances Neuroinflammation in Alzheimer's Disease

Cheng X, Wei Y, Qian Z, Han L.

Cell Mol Neurobiol. 2023 May;43(4):1537-1549. doi: 10.1007/s10571-022-01269-6. Epub 2022 Aug 12.

Natural remedies for Alzheimer's disease: A systematic review of randomized controlled trials

Ahmad S, Ahmed SB, Khan A, Wasim M, Tabassum S, Haider S, Ahmed F, Batool Z, Khaliq S, Rafiq H, Tikmani P, Gilani AU.

Metab Brain Dis. 2023 Jan;38(1):17-44. doi: 10.1007/s11011-022-01063-9. Epub 2022 Aug 12.

Pinpointing the locus of GABAergic vulnerability in Alzheimer's disease

Melgosa-Ecenarro L, Doostdar N, Radulescu CI, Jackson JS, Barnes SJ.

Semin Cell Dev Biol. 2023 Apr;139:35-54. doi: 10.1016/j.semcdb.2022.06.017. Epub 2022 Aug 10.

Aß Pathology and Neuron-Glia Interactions: A Synaptocentric View

Huffels CFM, Middeldorp J, Hol EM.

Neurochem Res. 2023 Apr;48(4):1026-1046. doi: 10.1007/s11064-022-03699-6. Epub 2022 Aug 17.

Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights

Sanaie S, Nikanfar S, Kalekhane ZY, Azizi-Zeinalhajlou A, Sadigh-Eteghad S, Araj-Khodaei M, Ayati MH, Andalib S.

Metab Brain Dis. 2023 Jan;38(1):137-162. doi: 10.1007/s11011-022-01059-5. Epub 2022 Aug 20.

Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics

Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH.

Inflammation. 2023 Feb;46(1):1-17. doi: 10.1007/s10753-022-01721-1. Epub 2022 Aug 20.

Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease

Bhatia S, Singh M, Singh T, Singh V.

Neurochem Res. 2023 Jan;48(1):13-25. doi: 10.1007/s11064-022-03722-w. Epub 2022 Aug 20.

Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer's Disease: a Review of Mechanism of Activation, Regulation, and Inhibition

Sharma B, Satija G, Madan A, Garg M, Alam MM, Shaquiquzzaman M, Khanna S, Tiwari P, Parvez S, Iqubal A, Haque SE, Khan MA.

Inflammation. 2023 Feb;46(1):56-87. doi: 10.1007/s10753-022-01730-0. Epub 2022 Aug 25.

Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments

Seyedaghamiri F, Rajabi M, Mohaddes G.

Neurochem Res. 2023 Jan;48(1):26-38. doi: 10.1007/s11064-022-03734-6. Epub 2022 Sep 1.

Inflammasome activation in traumatic brain injury and Alzheimer's disease

Johnson NH, de Rivero Vaccari JP, Bramlett HM, Keane RW, Dietrich WD.

Transl Res. 2023 Apr;254:1-12. doi: 10.1016/j.trsl.2022.08.014. Epub 2022 Sep 5.

Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions

Lim D, Tapella L, Dematteis G, Talmon M, Genazzani AA.

Neurochem Res. 2023 Apr;48(4):1077-1090. doi: 10.1007/s11064-022-03744-4. Epub 2022 Sep 9.

An insight into the neuroprotective effects and molecular targets of pomegranate (Punica granatum) against Alzheimer's disease

George N, AbuKhader M, Al Balushi K, Al Sabahi B, Khan SA.

Nutr Neurosci. 2023 Oct;26(10):975-996. doi: 10.1080/1028415X.2022.2121092. Epub 2022 Sep 20.

Development of new Alzheimer's disease drug candidates using donepezil as a key model

Eissa KI, Kamel MM, Mohamed LW, Kassab AE.

Arch Pharm (Weinheim). 2023 Jan;356(1):e2200398. doi: 10.1002/ardp.202200398. Epub 2022 Sep 23.

Pin1 and Alzheimer's disease

Malter JS.

Transl Res. 2023 Apr;254:24-33. doi: 10.1016/j.trsl.2022.09.003. Epub 2022 Sep 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias